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CheY, a response regulator protein in bacterial chemotaxis, serves
as a prototype for the analysis of response regulator function in
two-component signal transduction. Phosphorylation of a con-
served aspartate at the active site mediates a conformational
change at a distal signaling surface that modulates interactions
with the flagellar motor component FliM, the sensor kinase CheA,
and the phosphatase CheZ. The objective of this study was to probe
the conformational coupling between the phosphorylation site
and the signaling surface of CheY in the reverse direction by
quantifying phosphorylation activity in the presence and absence
of peptides of CheA, CheZ, and FliM that specifically interact with
CheY. Binding of these peptides dramatically impacted autophos-
phorylation of CheY by small molecule phosphodonors, which is
indicative of reverse signal propagation in CheY. Autodephospho-
rylation and substrate affinity, however, were not significantly
affected. Kinetic characterization of several CheY mutants sug-
gested that conserved residues Thr-87, Tyr-106, and Lys-109, im-
plicated in the activation mechanism, are not essential for
conformational coupling. These findings provide structural and
conceptual insights into the mechanism of CheY activation. Our
results are consistent with a multistate thermodynamic model of
response regulator activation.
Two-component regulatory systems, composed of a sensorkinase and its cognate response regulator, are widely used to
accomplish signal transduction in bacteria, archaea, lower eu-
karyotes, and plants (1). CheY, a response regulator protein in
bacterial chemotaxis, serves as a prototype to study the function
of this class of proteins. In its active, phosphorylated form, CheY
exhibits enhanced binding to a switch component, FliM, at the
flagellar motor, which, in Escherichia coli, induces a change from
counterclockwise to clockwise (CW) flagellar rotation. Ulti-
mately, the phosphorylation status of CheY determines the
swimming behavior of the bacterial cell. CheY is phosphorylated
at Asp-57 with phosphoryl groups from the sensor kinase CheA
and subsequently is dephosphorylated with the assistance of
CheZ. CheY also exhibits an intrinsic autodephosphorylation
activity and can autophosphorylate by using small molecule
phosphodonors such as acetyl phosphate (AcP) or phosphor-
amidate (PAM; for review, see ref. 2). Genetic analysis as well
as NMR and x-ray crystallographic studies identified overlap-
ping binding surfaces for CheA, FliM, and CheZ on a-helix 4,
b-sheet 5, and a-helix 5 of CheY (3–12).
A series of genetic and biochemical studies indicate that
conserved residues Thr-87, Tyr-106, and Lys-109 play major
roles in the phosphorylation-mediated conformational change of
CheY. CheY mutants 87TA (13), 106YL (14), and 109KR (15),
for example, can be phosphorylated in vitro but fail to generate
a CW signal in vivo when introduced into a strain lacking
wild-type cheY. The recently solved crystal structures of beryl-
lofluoride (BeF3
2)-activated CheY (16) and two other phosphor-
ylated response regulators, FixJ and SpoOA (17, 18), indicate
that the conserved threonine and lysine (corresponding to
Thr-87 and Lys-109 in CheY) directly coordinate the phosphoryl
group at the active site. These structures, together with the NMR
structure of BeF3
2-activated CheY (19), implicate the conserved
threonine and tyrosine (corresponding to Tyr-106 in CheY) as
key residues in an activation mechanism in which relocation of
the threonine to directly interact with the aspartyl phosphate
causes a coordinated reorientation of the tyrosine side chain
from an outside, solvent-accessible conformation to an inside,
solvent-inaccessible conformation. The crystal structures of
nonphosphorylated CheY bound to a domain of CheA (9, 10)
and of BeF3
2-activated CheY bound to a peptide of FliM (12)
provide further evidence that the positioning of the Tyr-106 side
chain at the signaling surface of CheY is a major determinant for
the differential recognition of the phosphorylated and nonphos-
phorylated forms of CheY by its partner proteins. Whereas
phosphorylation increases the affinity of CheY for FliM (20) and
CheZ (21), phosphorylation decreases the affinity of CheY for
CheA (22).
The objective of this study was to investigate the aforemen-
tioned conformational coupling between the phosphorylation
site and the signaling surface of CheY in the reverse direction.
There is evidence from the two-domain response regulator
OmpR that DNA binding at the C-terminal transcriptional
activation domain stimulates phosphorylation in the N-terminal
(‘‘CheY-like’’) receiver domain (23). Accordingly, we set out to
probe a conformational change of the single-domain response
regulator CheY by measuring its phosphorylation activity in the
presence and absence of peptides of CheA, CheZ, and FliM that
specifically interact with CheY. We found that peptide binding
dramatically impacts autophosphorylation activity, providing
evidence for reverse information f low in CheY. Results with
several CheY mutants showed that conserved residues 87, 106,
and 109 are individually not essential for conformational
coupling.
Materials and Methods
Bacterial Strains, Plasmids, and Mutant Constructions. The E. coli
D(cheYm60-21) strain K0641recA and the ptrp cheYZ plasmid
pRBB40 have been described (24). Derivatives of pRBB40
carrying mutant cheY alleles 87TA (13) and 109KR (25) have
been reported. cheY allele 106YA was constructed by splicing-
by-overlap-extension polynucleotide chain reaction (26). The
mutation generated was confirmed by sequencing the entire
cheY gene of the resulting pRBB40 plasmid.
Behavioral Assay. The rotational phenotype of strain KO641recA
carrying cheY106YA on plasmid pRBB40 was determined as
described (27).
Protein Purification and Peptide Synthesis. E. coli CheY (wild type
and mutant) and CheA proteins were purified from overexpress-
ing strains as described (28). Protein concentrations were de-
termined with a Lowry colorimetric assay (Bio-Rad).
CheA124–257, which includes the P2 domain of CheA, was puri-
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fied from strain RP3098 carrying plasmid pTM22 (29), as
described (5). Because of the lack of tryptophan residues in
CheA-P2, its concentration was determined by using a bicincho-
ninic acid assay (Pierce). The FliM peptide, corresponding to the
N-terminal 16 residues of FliM (MGDSILSQAEIDALLN) and
the CheZ peptides (wild type and 205VE), corresponding to the
C-terminal 19 residues of CheZ (AGVVASQDQVDDLLD-
SLGF and AGVVASQDQEDDLLDSLGF, respectively) were
obtained from Macromolecular Resources (Fort Collins, CO)
and from the University of North Carolina Program in Molec-
ular Biology and Biotechnology Micro Protein Chemistry Fa-
cility. Both peptides were purified by reverse-phase HPLC to a
chromatographic homogeneity of at least 90% to remove resid-
ual f luorescent contaminants.
Fluorescence Measurements of CheY Phosphorylation. Fluorescence
measurements were made on a Perkin–Elmer LS-50B spectrofluo-
rimeter; Perkin–Elmer FL WINLAB V.1.1 software was used to
operate the instrument and analyze data. Tryptophan fluorescence
of CheY was measured at an excitation wavelength of 292 nm and
an emission wavelength of 346 nm. Slit widths were adjusted to
accommodate the respective protein concentrations and varying
fluorescence intensities of the different CheY mutant proteins. The
minimum response time of the instrument is 20 ms. All samples
were maintained at 24.5–25.5°C with a circulating water bath.
Time courses of approach to steady-state phosphorylation
were monitored by following the decrease of intrinsic CheY
fluorescence that results from phosphorylation. To initiate the
reaction, CheY (wild type or mutant at 5 mM final concentra-
tion) was mixed with an equal volume of the phosphodonors
PAM or AcP (final concentration of 5–100 mM or 0.5–10 mM,
respectively) by using an Applied Photophysics (Surrey, U.K.)
RX2000 stopped-flow accessory (dead time 5 6 ms). All reac-
tions were carried out in 100 mM Hepes, pH 7.0y10 mM MgCl2.
At PAM concentrations below 100 mM, KCl was added to the
phosphodonor solution at the appropriate concentrations to
maintain constant ionic strength. Peptides were added to both
CheY and phosphodonor solutions at equal concentrations
before initiating the reaction. The final concentrations were 1
mM for CheZ or FliM peptide and 15 mM for CheA-P2. At these
ligand concentrations, '80% of CheY is bound to FliM or CheZ
peptide and '90% is bound to CheA-P2. Observed first-order
rate constants (kobs) were obtained by exponential analysis of the
resulting time courses. To determine the steady-state phosphor-
ylation properties of CheY, the relative fluorescence quenching
at steady state, taken from the individual stopped-flow experi-
ments, was plotted against PAM concentration.
For CheY mutants 87TA, 106YA, and 109KR, the phosphor-
ylation time courses in the absence of peptide were followed in
a standard cuvette; phosphodonor was added manually with a
Hamilton syringe through an injection port. The final protein
concentrations were 1.6 mM. Because the phosphorylation of
these mutants proceeded very slowly (for several minutes), the
high temporal resolution achieved by stopped-flow methods was
unnecessary. In addition, measurements performed by the
stopped-flow technique over longer time scales yielded time
courses that did not strictly obey first-order kinetics. This
discrepancy seems to be attributable to diffusion processes
between the reaction chamber and the reactants present in the
connecting tubing of the stopped-flow cuvette.
Results from pre-steady-state kinetics were analyzed accord-
ing to a reaction scheme of Lukat et al. (30). CheY phosphor-
ylation by AcP or PAM can be treated as a first-order reaction
with respect to phosphodonor concentration, and there is no
indication of saturation even at high substrate concentrations
(31, 32). Therefore, kobs can be expressed as follows:
kobs 5 ~kphosyKS! @Phosphodonor# 1 kdephos [1]
The quantity (kphosyKs) [Phosphodonor] represents an effective
rate constant for autophosphorylation. The ratio of (kobs 2
kdephos) to kobs thus yields the fraction of phosphorylated CheY
at a given phosphodonor concentration.
Binding Assay. Fluorescence measurements of the binding affin-
ities between CheY (wild type or mutant) and FliM or CheZ
peptide were performed as described (27). Dissociation con-
stants were determined by fitting the titration data to a quadratic
binding equation with the dissociation constant and total f luo-
rescence change as adjustable parameters (33). A single binding
site was assumed in the equation, and ligand concentration was
corrected for the amount bound to CheY. The standard error
given by the graphing software is an indicator for the accuracy
of fit to a single data set. Background fluorescence associated
with CheZ or FliM peptides was subtracted from the observed
fluorescence signal. Measurement of peptide binding to phos-
phorylated CheY mutants 87TA and 109KR was complicated by
the fact that a significant fraction of CheY was present in the
nonphosphorylated form even after the addition of 100 mM
PAM. Based on the measured rate constants, kobs at 100 mM
PAM (see Fig. 2) and kdephos (Table 1), the phosphorylated
fraction was estimated to be 63% for CheY87TA and 75% for
CheY109KR (Eq. 1). Therefore, the resulting fluorescence
change upon titration with FliM peptide contained a contribu-
tion resulting from initial FliM peptide binding to nonphospho-
rylated CheY and subsequent phosphorylation of this species
(complete phosphorylation was assumed). These fluorescence
contributions could be calculated based on measurements of the
respective binding and phosphorylation reactions and were
subtracted from the overall f luorescence signal.
For binding measurements between wild-type CheY and
BeF3
2, 1.6 mM CheY in the absence of peptide and 0.4 mM CheY
in the presence of 1 mM FliM peptide were titrated with
increasing amounts of BeCl2 in 100 mM Hepes, pH 7.0y10 mM
MgCl2y10 mM NaF. Under these conditions, the most likely
species to interact with CheY is BeF3
2 (34).
Fig. 1. Phosphorylation kinetics of wild-type CheY by PAM. Reactions were
performed in the absence of peptide (E), the presence of 1 mM FliM peptide
(h), the presence of 1 mM CheZ peptide (L), the presence of 15 mM CheA-P2
(‚), or the presence of 1 mM CheZ205VE peptide (3). Measurements were
done with a stopped-flow instrument, and constant ionic strength was main-
tained. Observed first-order rate constants (kobs) were determined from indi-
vidual phosphorylation time courses at the indicated phosphodonor concen-
trations. For clarity, kobs values obtained in the absence of peptide (E) and in
the presence of CheA-P2 (‚) are replotted in Inset with a different y-axis scale.
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Dephosphorylation Assays. Measurement of the rates of autode-
phosphorylation of phosphorylated CheY proteins was based on
a published assay (35). Purified [32P]CheA (28 pmol) was
incubated with 400 pmol of CheY (wild type or mutant) in a
100-ml reaction containing 100 mM Hepes, pH 7.0y20 mM
MgCl2 at 25°C. KCl was added to maintain a level of ionic
strength identical to the stopped-f low reaction conditions.
Where appropriate, CheA-P2 (15 mM final concentration), FliM
(1 mM final concentration), or CheZ peptide (1 mM final
concentration) was added a few seconds after CheY had been
incubated with [32P]CheA. Aliquots of 10 ml were removed at
various times, added to 23 Laemmli denaturing buffer, and
separated by SDSyPAGE. Relative amounts of [32P]CheY were
determined by phosphorimaging. Exponential analysis of the
time courses yielded first-order rate constants. To assess the
sensitivity of CheY (wild type or 106YA) to CheZ, 15 or 150
pmol CheZ was added to the reaction.
Results
Phosphorylation Kinetics of Wild-Type CheY. The effect of CheA,
CheZ, and FliM on the phosphorylation properties of CheY was
assessed by following the phosphorylation-associated decrease
in tryptophan fluorescence. Instead of full-length protein, only
fragments of CheA, CheZ, and FliM that interact with CheY
were used in the respective phosphorylation and binding reac-
tions. Full-length proteins would obscure fluorescence measure-
ments because of the presence of additional tryptophan residues,
and in the case of CheZ, dephosphorylation activity would
interfere with the effect of binding on the phosphorylation
properties of CheY. Peptides of CheZ (36) and FliM (37),
corresponding to the C-terminal 19 aa of CheZ and the N-
terminal 16 aa of FliM, respectively, and a single domain of
CheA (termed CheA-P2; refs. 7 and 29) have been shown to bind
specifically to CheY in a phosphorylation-dependent fashion.
We measured the pre-steady-state kinetics of CheY phosphor-
ylation by the small molecule phosphodonor PAM in the pres-
ence and absence of peptide ligand. The associated time-
dependent decrease in CheY fluorescence was monitored by
using a stopped-flow apparatus with a resolution in the milli-
second range, and the values of the corresponding observed
phosphorylation rate constants (kobs) were plotted as a function
of the PAM concentration (Fig. 1). The data in both the presence
and absence of ligand indicated a linear dependence on phos-
phodonor concentrations with no indication of substrate satu-
ration at concentrations up to 100 mM, consistent with another
study (32). These results suggested that the binding affinity of
CheY for phosphodonor is very low (KS .. 100 mM) even in the
presence of CheZ or FliM peptide. On the other hand, the slope
of the rate of CheY phosphorylation was increased by at least an
order of magnitude in the presence of either peptide and
decreased '6-fold in the presence of CheA-P2. The slope
corresponds to the catalytic efficiency of CheY, which is given by
the second-order rate constant of the reaction between CheY
and phosphodonor, kphosyKs (Eq. 1; see Table 1 for a summary
of rate constants determined in this study). In the absence of any
evidence for altered substrate affinity in the presence of peptide,
our data are consistent with the simple interpretation that
peptide binding primarily affects autophosphorylation activity
(i.e., kphos). Very similar results were obtained from experiments
with the phosphodonor AcP (data not shown). A control exper-
iment with a mutant CheZ peptide that binds CheY with greatly
decreased affinity (38) showed that the mere presence of peptide
in the phosphorylation reaction is not sufficient to affect CheY
phosphorylation significantly (Fig. 1).
The y-axis intercepts on the plot in Fig. 1 correspond to the
rate constants of dephosphorylation of phosphorylated CheY,
kdephos (Eq. 1). They seemed to be similar in all cases, which was
confirmed by measuring the decay of radiolabeled, phosphory-
lated CheY in the presence and absence of ligand (Table 1). In
conclusion, it appeared that binding of CheA-P2, CheZ, or FliM
peptide alters the autophosphorylation activity of CheY but has
no significant effect on its autodephosphorylation activity nor on
the affinity of CheY for its phosphodonor. Our results with
CheA-P2 confirmed and extended initial measurements by
Mayover et al. (31).
The effects of ligands on pre-steady-state kinetics were also
reflected in steady-state measurements of CheY phosphoryla-
tion (data not shown). Increasing PAM concentrations led to
increasing steady-state levels of phosphorylated CheY as assayed
by fluorescence quenching. Saturation was observed when es-
sentially all of the CheY present had been converted to the
phosphorylated form. As expected, the presence of FliM or
CheZ peptides greatly reduced the amount of phosphodonor
needed to convert CheY fully from the nonphosphorylated to
the phosphorylated form, whereas the presence of CheA-P2
increased the amount of phosphodonor needed.
Phosphorylation Kinetics of CheY Mutants. The results described
above suggested that ligand binding at the signaling surface of CheY
mediates a conformational change that can lead to altered phos-
phorylation activity. The simplest assumption is that this confor-
mational change involves the same conserved residues as the
phosphorylation-mediated conformational change, principally Thr-
87, Tyr-106, and Lys-109. As a possible mechanism, FliM or CheZ
peptide binding to nonphosphorylated CheY might mediate a
coordinated reorientation of the tyrosine and threonine side chains
toward the active site. Therefore, one might expect that ligand
binding has no appreciable impact on the phosphorylation activity
of CheY mutants that harbor amino acid substitutions at the
described positions. To test this hypothesis, we chose previously
characterized CheY mutants 87TA and 109KR, which can be
phosphorylated in vitro but do not promote CW flagellar rotation
in vivo in a DcheY host (13, 15). In addition, we generated a third
CheY mutant with a tyrosine-to-alanine substitution at position
106. The cheY106YA allele, introduced into a DcheY host on a
plasmid, also did not support CW flagellar rotation.
To assess the degree of conformational coupling in these
mutants, the pre-steady-state phosphorylation kinetics were
measured in the presence and absence of FliM peptide, as
described above for wild-type CheY (Fig. 2 and Table 1). All
mutants could be phosphorylated by PAM in vitro, albeit more
slowly than wild-type CheY, and phosphorylation activity (ex-
pressed as kobs) increased linearly with phosphodonor concen-
tration. Unexpectedly, all mutant proteins exhibited a consid-
erable increase in kobs values in the presence of FliM peptide,
indicative of significant conformational coupling between the
Table 1. Phosphorylation rate constants determined in this study
CheY variant Ligand kphosyKS (M21 z s21)* kdephos (s21)†
Wild type None 8.0 0.044
CheA-P2 1.4 0.038
CheZ peptide 100 0.045
CheZ205VE peptide 19 nyd
FliM peptide 230 0.068
87TA None 0.055 0.0033
FliM peptide 1.4 0.0082
106YA None 0.14 0.046
FliM peptide 4.4 0.038
109KR None 0.30 0.0097
FliM peptide 1.8 0.019
nyd, not determined.
*Determined using PAM as phosphodonor.
†Determined by radiolabeling.








signaling surface and the phosphorylation site. By contrast, the
effect of FliM binding on autodephosphorylation was relatively
minor (Table 1), suggesting that, as was observed for wild-type
CheY, peptide binding primarily affects autophosphorylation
activity in the mutant proteins.
It should be noted that, for CheY106YA in the absence of
peptide, the analysis of phosphorylation time courses that
yielded kobs contained a large margin for error because of very
low fluorescence quenching upon addition of phosphodonor.
The small decrease in fluorescence intensity also indicated that
only a marginal fraction of CheY106YA is present in the
phosphorylated form, which is consistent with the relatively low
values obtained for kobs (Fig. 2) compared with kdephos (Table 1).
Peptide Binding. Communication between the signaling surface
and the phosphorylation site in CheY mutants with substitutions
at positions 87, 106, and 109 should also be reflected in their
ability to bind to FliM with increased affinity upon phosphor-
ylation. A previous bead-binding assay, however, indicated that
the phosphorylated and unphosphorylated forms of CheY mu-
tant 109KR bind to full-length FliM with similar affinities (39).
To obtain more quantitative results, we measured binding of this
mutant as well as CheY87TA and CheY106YA to FliM peptide
by fluorescence spectroscopy (Fig. 3). Indeed, phosphorylation
resulted in a 4.5-fold increase in the affinity of CheY87TA and
a 2-fold increase in the affinity of CheY109KR to FliM peptide
compared with a 10-fold increase for wild-type CheY. However,
the absolute affinity of the phosphorylated species to peptide
was lower for the mutants than for wild-type CheY. It was not
feasible to determine the affinity of phosphorylated
CheY106YA to FliM peptide accurately, because even in the
presence of high concentrations of PAM, only a small fraction
of CheY106YA was present in the phosphorylated form (see
above).
Discussion
Stimulation of phosphorylation activity upon binding to a target
was first noted in the two-domain response regulator OmpR
(23). In this study, we provide evidence suggesting that this
observation may be a general phenomenon that affects all
response regulators, even those with a single domain such as
CheY. Our results indicate that the interaction of CheY with
parts of CheA, CheZ, and FliM dramatically affects autophos-
phorylation activity. For most kinetic assays, we used fluores-
cence spectroscopy, in which the phosphorylation activity of
CheY is inferred from changes in the environment of the
fluorophore, Trp-58, at the active site. Although this technique
is indirect, agreement of the data with the current kinetic model
for CheY phosphorylation strongly suggested that measure-
ments obtained by fluorescence indeed reflect altered phos-
phorylation activity of CheY in the presence of ligand: the
measured time courses strictly obeyed first-order kinetics, the
deduced rate constants showed a first-order dependence with
respect to the phosphodonor concentration (Figs. 1 and 2) and
the autodephosphorylation rate constants, extrapolated from
fluorescence measurements (Figs. 1 and 2 and AcP data not
shown), agreed well with results obtained from radiolabeling
(Table 1).
A Phenomenon Preordained by Thermodynamics? Results from pre-
steady-state kinetics implied that ligand binding primarily af-
fected autophosphorylation, whereas autodephosphorylation as
well as binding of phosphodonor to CheY remained unaltered
(Fig. 1 and Table 1). Autophosphorylation was increased '10-
fold and '30-fold by CheZ and FliM peptides, respectively, but
was reduced 6-fold by CheA-P2. This differential effect corre-
lated well with the binding affinities of these ligands to CheY:
FliM and CheZ peptide bound '10-fold more tightly to the
phosphorylated form of CheY (Fig. 3 and data not shown), and
CheA-P2 bound '6-fold more tightly to the nonphosphorylated
form (7, 22). The apparent coupling between ligand binding and
phosphorylation activity can be described by a four-state model
(23) representing a thermodynamic box of equilibria (Fig. 4A).
CheY exists in two phosphorylation equilibria, one in the
absence and one in the presence of ligand, and two binding
equilibria, one with the nonphosphorylated and one with the
phosphorylated species of CheY. In such a system, the ratio of
the two phosphorylation equilibrium constants must equal the
ratio of the two binding equilibrium constants, because the free
energy of a reaction is directly proportional to the logarithm of
the equilibrium constant, and the free energy difference be-
tween two species must be the same regardless of the path taken
between the two species. The equilibrium constants for the
phosphorylation reactions are simply the ratios of the rate
constants of the forward and reverse reaction. For wild-type
CheY, the ratio of the forward phosphorylation rate constants in
Fig. 2. Phosphorylation kinetics of CheY mutants by PAM. Reactions with
CheY87TA (E,F), CheY106YA (h,■), and CheY109KR (L,l) were performed
in the absence (open symbols) and the presence (closed symbols) of 1 mM FliM
peptide. Observed first-order rate constants (kobs) were determined from
individual phosphorylation time courses at the indicated phosphodonor con-
centrations. Constant ionic strength was maintained.
Fig. 3. Binding of FliM peptide to CheY mutants. CheY87TA (E,F),
CheY106YA (h), CheY109KR (L,l), and wild-type CheY (‚,Œ), were titrated
with FliM peptide in the absence (open symbols) or the presence (closed
symbols) of 100 mM PAM. The fraction of CheY bound to peptide is given by
the relative decrease in fluorescence intensity (DIyDImax). The dissociation
constants in the absence and presence of PAM are, respectively (in mM), 260 6
13 and 25 6 1 for wild-type CheY, 181 6 16 and 40 6 3 for CheY87TA, 508 6
39 for CheY106YA, and 211 6 9 and 100 6 3 for CheY109KR.
6006 u www.pnas.orgycgiydoiy10.1073ypnas.101571298 Schuster et al.
the presence and absence of ligand is similar to the ratio of the
equilibrium constants for peptide binding in the presence and
absence of phosphorylation. Thus, we can infer that peptide
binding must not significantly affect the rate of the reverse
phosphorylation reaction, i.e., transfer of a phosphoryl group
from CheY to ammonia or acetate to form PAM or AcP,
respectively. To our knowledge, no attempts have been made to
quantify this extremely unfavorable reaction.
A related thermodynamic box can be constructed if the
phosphorylation reactions with small molecule phosphodonors
are replaced by binding reactions with the phosphate analog
BeF3
2. BeF3
2 has been shown to form a stable complex with CheY
that mimics its activated state (19, 40). In this case, therefore, it
is possible to measure all four equilibria. We measured the
binding affinity of CheY to BeF3
2 in the presence and absence
of FliM peptide (Fig. 5). CheY bound '10-fold more tightly to
BeF3
2 when associated with FliM peptide. This result correlated
very well with the 10-fold tighter binding of CheY to FliM
peptide in the presence of BeF3
2 (40) than in its absence (Fig. 3).
Structural Implications. The impact of ligand binding on autophos-
phorylation but not on autodephosphorylation (Fig. 1 and Table
1) suggested that ligand binding changes the conformation of
nonphosphorylated CheY but not that of phosphorylated CheY.
The notion of a propagating conformational change in nonphos-
phorylated CheY upon ligand binding is supported by recent
structural studies. Chemical shift changes in NMR spectra of
CheY in the presence of CheZ or FliM peptides were observed
not only in C-terminal regions of the protein that constitute the
putative ligand-binding surface, but also at the distally located
phosphorylation site (11). Asp-57, Thr-87, Tyr-106, and Lys-109
were among the residues affected, consistent with the concept
that this conformational change involves the same structural
elements as the conformational change mediated by phosphor-
ylation. Moreover, in two crystal structures of a complex of
CheY and the P2 domain of CheA, the CheY active site was
found in a more ‘‘open’’ conformation compared with apo-CheY
(9, 10). According to our results, this conformation seems to
reduce rather than increase reactivity toward small molecule
phosphodonors (Fig. 1). The enormous rate enhancement in
CheA-mediated phosphotransfer may be caused, therefore, sim-
ply by an increase in the local concentration of phosphodonor
(31). To explain the dramatic effect on the phosphorylation
kinetics of CheY, ligand binding may induce or stabilize a
conformation at the phosphorylation site of CheY that stabilizes
(or, in case of CheA-P2, destabilizes) a transition state during
autophosphorylation. The conserved threonine and lysine (as
well as the Mg21) likely participate in this process, because they
have been shown to coordinate the fluorines in BeF3
2-activated
CheY (16) and the phosphoryl oxygens in other phosphorylated
response regulators (17, 18). Our conclusion that ligand binding
does not significantly alter the conformation of phosphorylated
CheY is supported by the high similarity of the recently solved
structures of BeF3
2-activated CheY alone (16, 19) and in complex
with a peptide of FliM (12).
Interesting insights are obtained when the concept of an
equilibrium between active and inactive states is applied to the
described conformational changes in CheY. In the original
model, phosphorylation is coupled to a protein conformational
change in the absence of any peptide ligand (1, 41, 42). This
equilibrium favors the inactive conformation in the absence of
phosphorylation but favors the activated conformation in the
presence of phosphorylation. Our results imply the existence of
additional equilibria that also couple the binding of ligand to a
protein conformational change. Consequently, not only phos-
phorylation but also binding of CheZ or FliM peptides would
stabilize the active conformation of CheY. It follows that
phosphorylation increases peptide binding, and peptide binding
enhances phosphorylation activity. CheA-P2, in contrast, would
stabilize the inactive conformation of CheY rather than induce
a new conformation. This idea is supported by the structure of
CheY bound to CheA-P2 as determined by Welch et al. (10). In
this complex, CheY is virtually identical to the structure of
CheY87TI (43), a mutant presumably locked in an inactive
conformation. Based on Fig. 4A, the equilibria described here
may be integrated into a model of CheY activation that recog-
nizes eight individual states (Fig. 4B).
A recent crystallographic study suggests that the interaction
between the conserved active site lysine and the aspartyl phos-
phate is directly involved in the activation of response regulators
in addition to the emphasized coordinated rearrangement of the
conserved threonine and tyrosineyphenylalanine residues (16).
This ‘‘branched’’ mechanism can account for our observation
that CheY mutant proteins lacking either Thr-87, Tyr-106, or
Fig. 4. Models of CheY activation. (A) Four-state model. The model describes
a thermodynamic box of equilibria for coupling of the binding of a ligand to
the phosphorylation of CheY. ‘‘P’’ denotes a phosphoryl group and ‘‘L’’
denotes a peptide ligand. Colored arrows indicate a shift of the respective
equilibria in the presence of FliM or CheZ peptide (green) or CheA-P2 (red). See
the text for further explanation. (B) Eight-state model. The described four-
state model is expanded by equilibria that couple phosphorylation and ligand
binding to a protein conformational change. Ellipses denote an inactive, and
rectangles denote an active conformation. Equilibria are thought to be dis-
tributed as follows. ➀ is favored in the absence of phosphorylation and ligand.
Phosphorylation stabilizes ➁ (blue). Binding of CheA-P2 stabilizes ➂ (red),
whereas binding of FliM or CheZ peptide stabilizes ➃ (green). Already in active
conformations, ➁ binds CheZ or FliM peptide with increased affinity, and ➃,
with CheZ or FliM peptide as ligands, phosphorylates rapidly to favor ➄. On the
other hand, ➁ is in an unfavorable conformation to bind CheA-P2, and ➂, with
CheA-P2 as ligand, is in an unfavorable conformation to autophosphorylate.
Fig. 5. Binding of BeF3
2 to CheY. Wild-type CheY in reaction buffer contain-
ing 10 mM NaF was titrated with BeCl3 in the absence (E) or presence (h) of
1 mM FliM peptide. The fraction of CheY bound to peptide is given by the
relative decrease in fluorescence intensity (DIyDImax). The dissociation con-
stants are 7.7 6 0.7 mM in the absence of peptide and 0.81 6 0.04 mM in the
presence of peptide.








Lys-109 exhibited mostly reduced—but in all cases significant—
conformational coupling in both directions (Figs. 2 and 3). In
these mutants, conformational coupling would predominantly
occur through the respective alternate branch that is still func-
tional, i.e., through Thr-87yTyr-106 or Lys-109. The extent of
coupling, although substantial, was apparently not sufficient to
promote CW flagellar rotation in a DcheY host, which implied
that all three residues function synergistically to activate CheY
fully. It would appear that the modest decrease in binding
observed for CheY87TA and CheY109KR compared with wild-
type CheY (Fig. 3) is sufficient to account for their loss-of-
function phenotype (13, 15), because the interaction of CheY
with the flagellar switch is highly cooperative (44). This expla-
nation is likely to be true for CheY106YA as well, although the
affinity of this mutant protein to FliM peptide could not be
measured. The phenotype of these mutants is probably not
caused by a decrease in the cellular concentration of phosphor-
ylated CheY, as inferred from the in vitro measurements of
CheA- and CheZ-mediated phosphorylation reactions (refs. 13,
15, and 35 and data not shown), which would be the primary
route of phosphoryl group flow in vivo.
Relevance in Vivo. Ames et al. (23) have suggested that the
response regulator OmpR may be phosphorylated while it is
bound to its target, which can be envisioned for CheY as well.
In this case, small molecule phosphodonors would remain the
sole relevant phosphodonor in vivo, because the kinase CheA, as
part of the chemotaxis receptor complex, is physically separated
from the flagellar switch (2). Assuming a cytoplasmic concen-
tration of 35 mM for nonphosphorylated CheY at steady state
(45) and a switch-binding affinity of 100 mM (which is '10-fold
weaker than that estimated for phosphorylated CheY; refs. 45
and 46), '30% of switch-binding sites would be occupied by
nonphosphorylated CheY. Cellular AcP concentrations can
reach up to 1.5 mM (47), at which point a significant fraction of
CheY molecules would be phosphorylated while bound to the
flagellar switch. AcP levels, as a physiological indicator, might
thus be integrated into the chemotaxis response by modulating
the prestimulus swimming behavior of the bacterium.
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